Search

Author/Creator Hupperts, Raymond

4. Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study. (August 2015)

Authors:
Bayas, Antonios; Ouallet, Jean Christophe; Kallmann, Boris; Hupperts, Raymond; Fulda, Ulrich; Marhardt, Kurt
Journal:
Expert opinion on drug delivery
Issue:
Volume 12:Number 8(2015:Aug.)
Page Start:
1239
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis. (October 2018)

Authors:
Kalincik, Tomas; Jokubaitis, Vilija; Spelman, Tim; Horakova, Dana; Havrdova, Eva; Trojano, Maria; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Prat, Alexandre; Girard, Marc; Duquette, Pierre; Grammond, Pierre; Solaro, Claudio; Grand'Maison, Francois; Hupperts, Raymond; Prevost, Julie; Sola, Pa...
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 12(2018)
Page Start:
1617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing–remitting multiple sclerosis. (August 2015)

Authors:
Kalincik, Tomas; Jokubaitis, Vilija; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Grammond, Pierre; Lugaresi, Alessandra; Oreja-Guevara, Celia; Bergamaschi, Roberto; Hupperts, Raymond; Grand'Maison, Francois; Pucci, Eugenio; Van Pesch, Vincent; Boz, Cavit; Iuliano, Gerardo; Fernandez-Bol...
Other Names:
Roullet Etienne non-byline-author.; Rozsa Csilla non-byline-author.; Kasa Krisztian non-byline-author.; Sirbu Carmen-Adella non-byline-author.; Shaw Cameron non-byline-author.; Vucic Steve non-byline-author.; Petkovska-Boskova Tatjana non-byline-author.; Herbert Joseph non-byline-author.; Kister ...
Journal:
Multiple sclerosis
Issue:
Volume 21:Number 9(2015)
Page Start:
1159
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Comparative efficacy of switching to natalizumab in active multiple sclerosis. (27th February 2015)

Authors:
Spelman, Timothy; Kalincik, Tomas; Zhang, Annie; Pellegrini, Fabio; Wiendl, Heinz; Kappos, Ludwig; Tsvetkova, Larisa; Belachew, Shibeshih; Hyde, Robert; Verheul, Freek; Grand‐Maison, Francois; Izquierdo, Guillermo; Grammond, Pierre; Duquette, Pierre; Lugaresi, Alessandra; Lechner‐Scott, Jeannette...
Journal:
Annals of clinical and translational neurology
Issue:
Volume 2:Number 4(2015:Apr.)
Page Start:
373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial. Issue 7 (July 2022)

Authors:
Foley, John F; Defer, Gilles; Ryerson, Lana Zhovtis; Cohen, Jeffrey A; Arnold, Douglas L; Butzkueven, Helmut; Cutter, Gary; Giovannoni, Gavin; Killestein, Joep; Wiendl, Heinz; Smirnakis, Karen; Xiao, Shan; Kong, George; Kuhelj, Robert; Campbell, Nolan; van der Walt, Anneke; Dwyer, Christopher; Bu...
Journal:
Lancet neurology
Issue:
Volume 21:Issue 7(2022)
Page Start:
608
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Contribution of different relapse phenotypes to disability in multiple sclerosis. (February 2017)

Authors:
Stewart, Tamasine; Spelman, Tim; Havrdova, Eva; Horakova, Dana; Trojano, Maria; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Prat, Alexandre; Lugaresi, Alessandra; Grand'Maison, Francois; Grammond, Pierre; Sola, Patrizia; Shaygannejad, Vahid; Hupperts, Raymond; Alroughani, Raed; Oreja-Gu...
Journal:
Multiple sclerosis
Issue:
Volume 23:Number 2(2017)
Page Start:
266
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗